Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Origin issues update on R&D pipeline

Chinese agricultural biotechnology company Origin Agritech (Beijing) is to expand the number of maize hybrids incorporating a genetic modification that results in the production of the enzyme, phytase, in grain. It already has two hybrid lines awaiting final approval from Chinese regulators and is now seeking to add the trait to a further two hybrid lines. The availability of grain for feed that incorporates phytase will reduce feed manufacturers’ costs by eliminating the need for the use of an additive, the company says. The phytase-producing maize will also reduce the need for adding inorganic phosphate supplements to feed as animals will directly absorb more phosphate from their feed, reducing costs, it adds.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts